Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome

Fertility and Sterility

Volumn 105, Issue 6, 2016, Pages 1594-1602.e3

  Cesta, Carolyn E ^a   Viktorin, Alexander ^a   Olsson, Henrik ^a   Johansson, Viktoria ^a   Sjölander, Arvid ^a   Bergh, Christina ^b   Skalkidou, Alikistis ^c   Nygren, Karl Gösta ^a   Cnattingius, Sven ^a   Iliadou, Anastasia N ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antidepressants; depression; epidemiology; in vitro fertilization; IVF outcome

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; REBOXETINE; SERTRALINE; TRIMIPRAMINE; TRYPTOPHAN; VENLAFAXINE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SPONTANEOUS ABORTION; SWEDEN; ADOLESCENT; ANXIETY; IN VITRO FERTILIZATION; LONGITUDINAL STUDY; MIDDLE AGED; PREGNANCY; PREGNANCY RATE; PROCEDURES; REGISTER; TREATMENT OUTCOME; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY; COHORT STUDIES; DEPRESSION; FEMALE; FERTILIZATION IN VITRO; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PREGNANCY; PREGNANCY RATE; REGISTRIES; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959286631     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2016.01.036     Document Type: Article

References (51)

1. 1 Kupka, M.S., Ferraretti, A.P., de Mouzon, J., Erb, K., D'Hooghe, T., Castilla, J.A., et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE. Hum Reprod 29 (2014), 2099–2113.
2. 2 Williams, K.E., Marsh, W.K., Rasgon, N.L., Mood disorders and fertility in women: a critical review of the literature and implications for future research. Hum Reprod Update 13 (2007), 607–616.
3. 3 Volgsten, H., Skoog Svanberg, A., Ekselius, L., Lundkvist, O., Sundstrom Poromaa, I., Prevalence of psychiatric disorders in infertile women and men undergoing in vitro fertilization treatment. Hum Reprod 23 (2008), 2056–2063.
4. 4 Johansson, R., Carlbring, P., Heedman, A., Paxling, B., Andersson, G., Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ, 1, 2013, e98.
5. 5 Thiering, P., Beaurepaire, J., Jones, M., Saunders, D., Tennant, C., Mood state as a predictor of treatment outcome after in vitro fertilization/embryo transfer technology (IVF/ET). J Psychosom Res 37 (1993), 481–491.
6. 6 Smeenk, J.M., Verhaak, C.M., Eugster, A., van Minnen, A., Zielhuis, G.A., Braat, D.D., The effect of anxiety and depression on the outcome of in-vitro fertilization. Hum Reprod 16 (2001), 1420–1423.
7. 7 Boivin, J., Schmidt, L., Infertility-related stress in men and women predicts treatment outcome 1 year later. Fertil Steril 83 (2005), 1745–1752.
8. 8 Li, X.H., Ma, Y.G., Geng, L.H., Qin, L., Hu, H., Li, S.W., Baseline psychological stress and ovarian norepinephrine levels negatively affect the outcome of in vitro fertilisation. Gynecol Endocrinol 27 (2011), 139–143.
9. 9 Matthiesen, S.M., Frederiksen, Y., Ingerslev, H.J., Zachariae, R., Stress, distress and outcome of assisted reproductive technology (ART): a meta-analysis. Hum Reprod 26 (2011), 2763–2776.
10. 10 Turner, K., Reynolds-May, M.F., Zitek, E.M., Tisdale, R.L., Carlisle, A.B., Westphal, L.M., Stress and anxiety scores in first and repeat IVF cycles: a pilot study. PLoS One, 8, 2013, e63743.
11. 11 Csemiczky, G., Landgren, B.M., Collins, A., The influence of stress and state anxiety on the outcome of IVF-treatment: psychological and endocrinological assessment of Swedish women entering IVF-treatment. Acta Obstet Gynecol Scand 79 (2000), 113–118.
12. 12 Harlow, C.R., Fahy, U.M., Talbot, W.M., Wardle, P.G., Hull, M.G., Stress and stress-related hormones during in-vitro fertilization treatment. Hum Reprod 11 (1996), 274–279.
13. 13 Emery, M., Beran, M.D., Darwiche, J., Oppizzi, L., Joris, V., Capel, R., et al. Results from a prospective, randomized, controlled study evaluating the acceptability and effects of routine pre-IVF counselling. Hum Reprod 18 (2003), 2647–2653.
14. 14 Anderheim, L., Holter, H., Bergh, C., Moller, A., Does psychological stress affect the outcome of in vitro fertilization?. Hum Reprod 20 (2005), 2969–2975.
15. 15 Lintsen, A.M., Verhaak, C.M., Eijkemans, M.J., Smeenk, J.M., Braat, D.D., Anxiety and depression have no influence on the cancellation and pregnancy rates of a first IVF or ICSI treatment. Hum Reprod 24 (2009), 1092–1098.
16. 16 Pasch, L.A., Gregorich, S.E., Katz, P.K., Millstein, S.G., Nachtigall, R.D., Bleil, M.E., et al. Psychological distress and in vitro fertilization outcome. Fertil Steril 98 (2012), 459–464.
17. 17 Boivin, J., Griffiths, E., Venetis, C.A., Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies. BMJ, 342, 2011, d223.
18. 18 Yli-Kuha, A.N., Gissler, M., Klemetti, R., Luoto, R., Koivisto, E., Hemminki, E., Psychiatric disorders leading to hospitalization before and after infertility treatments. Hum Reprod 25 (2010), 2018–2023.
19. 19 Sejbaek, C.S., Hageman, I., Pinborg, A., Hougaard, C.O., Schmidt, L., Incidence of depression and influence of depression on the number of treatment cycles and births in a national cohort of 42,880 women treated with ART. Hum Reprod 28 (2013), 1100–1109.
20. 20 Baldur-Felskov, B., Kjaer, S.K., Albieri, V., Steding-Jessen, M., Kjaer, T., Johansen, C., et al. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study. Hum Reprod 28 (2013), 683–690.
21. 21 Agerbo, E., Mortensen, P.B., Munk-Olsen, T., Childlessness, parental mortality and psychiatric illness: a natural experiment based on in vitro fertility treatment and adoption. J Epidemiol Commun Health 67 (2013), 374–376.
22. 22 Meijer, W.E., Heerdink, E.R., Leufkens, H.G., Herings, R.M., Egberts, A.C., Nolen, W.A., Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 60 (2004), 57–61.
23. 23 Olfson, M., Marcus, S.C., National patterns in antidepressant medication treatment. Arch Gen Psychiatry 66 (2009), 848–856.
24. 24 Andrade, S.E., Raebel, M.A., Brown, J., Lane, K., Livingston, J., Boudreau, D., et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198 (2008), 194.e1–194.e5.
25. 25 Bakker, M.K., Kolling, P., van den Berg, P.B., de Walle, H.E., de Jong van den Berg, L.T., Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 65 (2008), 600–606.
26. 26 Stephansson, O., Granath, F., Svensson, T., Haglund, B., Ekbom, A., Kieler, H., Drug use during pregnancy in Sweden—assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol 3 (2011), 43–50.
27. 27 Friedman, B.E., Rogers, J.L., Shahine, L.K., Westphal, L.M., Lathi, R.B., Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome. Fertil Steril 92 (2009), 1312–1314.
28. 28 Serafini, P., Lobo, D.S., Grosman, A., Seibel, D., Rocha, A.M., Motta, E.L., Fluoxetine treatment for anxiety in women undergoing in vitro fertilization. Int J Gynaecol Obstet 105 (2009), 136–139.
29. 29 Klock, S.C., Sheinin, S., Kazer, R., Zhang, X., A pilot study of the relationship between selective serotonin reuptake inhibitors and in vitro fertilization outcome. Fertil Steril 82 (2004), 968–969.
30. 30 Ramezanzadeh, F., Noorbala, A.A., Abedinia, N., Rahimi Forooshani, A., Naghizadeh, M.M., Psychiatric intervention improved pregnancy rates in infertile couples. Malays J Med Sci 18 (2011), 16–24.
31. 31 Nikfar, S., Rahimi, R., Hendoiee, N., Abdollahi, M., Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: a systematic review and updated meta-analysis. Daru, 20, 2012, 75.
32. 32 Kjaersgaard, M.I., Parner, E.T., Vestergaard, M., Sorensen, M.J., Olsen, J., Christensen, J., et al. Prenatal antidepressant exposure and risk of spontaneous abortion: a population-based study. PLoS One, 8, 2013, e72095.
33. 33 Andersen, J.T., Andersen, N.L., Horwitz, H., Poulsen, H.E., Jimenez-Solem, E., Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol 124 (2014), 655–661.
34. 34 Johansen, R.L., Mortensen, L.H., Andersen, A.M., Hansen, A.V., Strandberg-Larsen, K., Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage: assessing potential biases. Paediatr Perinat Epidemiol 29 (2015), 72–81.
35. 35 Ludvigsson, J.F., Otterblad-Olausson, P., Pettersson, B.U., Ekbom, A., The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 24 (2009), 659–667.
36. 36 Ludvigsson, J.F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.L., Reuterwall, C., et al. External review and validation of the Swedish national inpatient register. BMC Public Health, 11, 2011, 450.
37. 37 Wettermark, B., Hammar, N., Fored, C.M., Leimanis, A., Otterblad Olausson, P., Bergman, U., et al. The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16 (2007), 726–735.
38. 38 Cnattingius, S., Ericson, A., Gunnarskog, J., Kallen, B., A quality study of a medical birth registry. Scand J Soc Med 18 (1990), 143–148.
39. 39 Furu, K., Wettermark, B., Andersen, M., Martikainen, J.E., Almarsdottir, A.B., Sorensen, H.T., The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106 (2010), 86–94.
40. 40 Chen, T.H., Chang, S.P., Tsai, C.F., Juang, K.D., Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Hum Reprod 19 (2004), 2313–2318.
41. 41 Herbert, D.L., Lucke, J.C., Dobson, A.J., Depression: an emotional obstacle to seeking medical advice for infertility. Fertil Steril 94 (2010), 1817–1821.
42. 42 Nakhai-Pour, H.R., Broy, P., Berard, A., Use of antidepressants during pregnancy and the risk of spontaneous abortion. Can Med Assoc J 182 (2010), 1031–1037.
43. 43 Ban, L., Tata, L.J., West, J., Fiaschi, L., Gibson, J.E., Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One, 7, 2012, e43462.
44. 44 Chun-Fai-Chan, B., Koren, G., Fayez, I., Kalra, S., Voyer-Lavigne, S., Boshier, A., et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192 (2005), 932–936.
45. 45 Harlow, B.L., Wise, L.A., Otto, M.W., Soares, C.N., Cohen, L.S., Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 60 (2003), 29–36.
46. 46 Joffe, H., Kim, D.R., Foris, J.M., Baldassano, C.F., Gyulai, L., Hwang, C.H., et al. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. J Clin Psychiatry 67 (2006), 297–304.
47. 47 Bisaga, K., Petkova, E., Cheng, J., Davies, M., Feldman, J.F., Whitaker, A.H., Menstrual functioning and psychopathology in a county-wide population of high school girls. J Am Acad Child Adolesc Psychiatry 41 (2002), 1197–1204.
48. 48 Kaihola, H., The effects of SSRI treatment on human placenta and embryo. Ph.D. diss, 2015, Uppsala University, Uppsala, Sweden.
49. 49 Hawkins, L.K., Rossi, B.V., Correia, K.F., Lipskind, S.T., Hornstein, M.D., Missmer, S.A., Perceptions among infertile couples of lifestyle behaviors and in vitro fertilization (IVF) success. J Assist Reprod Genet 31 (2014), 255–260.
50. 50 Barry, J.A., Kuczmierczyk, A.R., Hardiman, P.J., Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 26 (2011), 2442–2451.
51. 51 Facchin, F., Barbara, G., Saita, E., Mosconi, P., Roberto, A., Fedele, L., et al. Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol 36 (2015), 135–141.